MedPath
HSA Product

NUROFEN EXPRESS CAPLETS 684MG

Product approved by Health Sciences Authority (SG)

Basic Information

NUROFEN EXPRESS CAPLETS 684MG

TABLET, FILM COATED

Regulatory Information

SIN14367P

June 14, 2013

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XM01AE01

Company Information

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER (SINGAPORE) PTE LTD

Active Ingredients

Detailed Information

Contraindications

**Contraindications** Hypersensitivity to ibuprofen or any of the excipients in the product. Patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema, or urticaria) in response to aspirin or other non-steroidal anti-inflammatory drugs. Active or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding). History of gastrointestinal bleeding of perforation, related to previous NSAIDs therapy. Severe heart failure, renal failure or hepatic failure (see Special warnings and precautions for use – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). Last trimester of pregnancy (see Pregnancy and lactation – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). In patients who have recently undergone coronary artery bypass graft (CABG) surgery and revascularization procedures.

Indication Information

**Indications** Nurofen Express is indicated for the relief of pain such as headache, migraine pain, dental pain, period pain, rheumatic pain, muscular pain and backache. It also relieves fever such as fever associated with cold & flu.

© Copyright 2025. All Rights Reserved by MedPath